These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 27817998)

  • 1. [Economic consequences of biological monitoring and medical complications of injectable anticoagulants in France].
    Paubel P; Cousin M; Amar C; Gourmelen J; Fabron C; Detournay B
    J Mal Vasc; 2016 Dec; 41(6):371-377. PubMed ID: 27817998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose fondaparinux in suspected heparin-induced thrombocytopenia in the critically ill.
    Wester JP; Leyte A; Oudemans-van Straaten HM; Bosman RJ; van der Spoel JI; Haak EA; Porcelijn L; Zandstra DF
    Neth J Med; 2007 Mar; 65(3):101-8. PubMed ID: 17387236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fondaparinux cross-reacts with heparin antibodies in vitro in a patient with fondaparinux-related thrombocytopenia.
    Pistulli R; Oberle V; Figulla HR; Yilmaz A; Pfeifer R
    Blood Coagul Fibrinolysis; 2011 Jan; 22(1):76-8. PubMed ID: 21076279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of fondaparinux versus enoxaparin on in-hospital bleeding and 1-year death in non-ST-segment elevation myocardial infarction. FAST-MI (French Registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction) 2010.
    Puymirat E; Schiele F; Ennezat PV; Coste P; Collet JP; Bonnefoy-Cudraz E; Roul G; Richard P; Simon T; Danchin N
    Eur Heart J Acute Cardiovasc Care; 2015 Jun; 4(3):211-9. PubMed ID: 25075006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of platelet monitoring in patients receiving thromboprophylaxis with fondaparinux or a low molecular weight heparin. The Ariane study].
    Gouin-Thibault I; Liard F; Van-Ganse E; Vespa L; Gaudin AF; Nachit-Ouinekh F
    Presse Med; 2011 Sep; 40(9 Pt 1):e365-75. PubMed ID: 21515025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fondaparinux as a safe alternative for managing heparin-induced thrombocytopenia in postoperative cardiac surgery patients.
    Cegarra-Sanmartín V; González-Rodríguez R; Paniagua-Iglesias P; Santamaría-Ortiz A; Cueva LF; Galán-Serrano J; Moral-García MV
    J Cardiothorac Vasc Anesth; 2014 Aug; 28(4):1008-12. PubMed ID: 24439171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The incidence of heparin-induced thrombocytopenia in patients treated with low molecular weight heparin for superficial vein thrombosis.
    Sartori M; Favaretto E; Migliaccio L; Guazzaloca G; Legnani C; Palareti G; Cosmi B
    Thromb Res; 2016 Mar; 139():154-7. PubMed ID: 26916314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost and occurrence of thrombocytopenia in patients receiving venous thromboembolism prophylaxis following major orthopaedic surgeries.
    Happe LE; Farrelly EM; Stanford RH; Sarnes MW
    J Thromb Thrombolysis; 2008 Oct; 26(2):125-31. PubMed ID: 18034323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fondaparinux-associated heparin-induced thrombocytopenia.
    Bhatt VR; Aryal MR; Shrestha R; Armitage JO
    Eur J Haematol; 2013 Nov; 91(5):437-41. PubMed ID: 23905719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulation with fondaparinux for hemodiafiltration in patients with heparin-induced thrombocytopenia: dose-finding study and safety evaluation.
    Mahieu E; Claes K; Jacquemin M; Evenepoel P; Op De Beek K; Bogaert AM; Kuypers D; Verhamme P; Meijers B
    Artif Organs; 2013 May; 37(5):482-7. PubMed ID: 23461610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Hirsh J; Bauer KA; Donati MB; Gould M; Samama MM; Weitz JI
    Chest; 2008 Jun; 133(6 Suppl):141S-159S. PubMed ID: 18574264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin-induced thrombocytopenia in neurologic patients treated with low-molecular-weight heparin.
    Pohl C; Kredteck A; Bastians B; Hanfland P; Klockgether T; Harbrecht U
    Neurology; 2005 Apr; 64(7):1285-7. PubMed ID: 15824368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fondaparinux for the treatment of acute heparin-induced thrombocytopenia: a single-center experience.
    Grouzi E; Kyriakou E; Panagou I; Spiliotopoulou I
    Clin Appl Thromb Hemost; 2010 Dec; 16(6):663-7. PubMed ID: 19825921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fondaparinux-related thrombocytopenia in a previous low-molecular-weight heparin (LMWH)-induced heparin-induced thrombocytopenia (HIT).
    Rota E; Bazzan M; Fantino G
    Thromb Haemost; 2008 Apr; 99(4):779-81. PubMed ID: 18392338
    [No Abstract]   [Full Text] [Related]  

  • 15. Heparin-induced thrombocytopenia associated with fondaparinux.
    Chong BH; Chong JJ
    Clin Adv Hematol Oncol; 2010 Jan; 8(1):63-5. PubMed ID: 20351686
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevalence and risk of preexisting heparin-induced thrombocytopenia antibodies in patients with acute VTE.
    Warkentin TE; Davidson BL; Büller HR; Gallus A; Gent M; Lensing AWA; Piovella F; Prins MH; Segers AEM; Kelton JG
    Chest; 2011 Aug; 140(2):366-373. PubMed ID: 21393394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Fondaparinux in Patients With Suspected Heparin-Induced Thrombocytopenia.
    Snodgrass MN; Shields J; Rai H
    Clin Appl Thromb Hemost; 2016 Nov; 22(8):712-717. PubMed ID: 27179015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin-induced thrombocytopenia: an estimate of the average cost in the hospital setting in France.
    Elalamy I; Le Gal G; Nachit-Ouinekh F; Lafuma A; Emery C; Le-Fur C; Chapuis F
    Clin Appl Thromb Hemost; 2009; 15(4):428-34. PubMed ID: 18544593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fondaparinux for the treatment of patients with acute heparin-induced thrombocytopenia.
    Lobo B; Finch C; Howard A; Minhas S
    Thromb Haemost; 2008 Jan; 99(1):208-14. PubMed ID: 18217156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparins, low-molecular-weight heparins, and pentasaccharides.
    Dinwoodey DL; Ansell JE
    Clin Geriatr Med; 2006 Feb; 22(1):1-15, vii. PubMed ID: 16377464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.